Skip to main content
. 2021 Dec 8;9(2):391–409. doi: 10.1007/s40744-021-00404-x

Fig. 3.

Fig. 3

Expression of immune cell type-specific gene signatures from baseline to year 2. *Profiles which were significantly different (p < 0.05; t test) between treatments at year 2. IL interleukin, IZ isoleucine zipper, MFI mean fluorescence intensity, NK natural killer, PMN polymorphonuclear, SC subcutaneous, SE standard error